Results 91 to 100 of about 417,620 (216)

Efficacy of conjugate vaccines in pneumococcal infection prevention

open access: yesЖурнал инфектологии, 2014
The problem of pneumococcal infection is actual for many countries of the world in connection with high incidence and mortality. Vaccination by the 7-valent conjugated pneumococcal vaccine of children till 2 years is available in Russia since 2009, 13 ...
A. L. Perova   +2 more
doaj   +1 more source

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

open access: yesPLoS ONE, 2017
Introduction S. pneumoniae can cause a wide spectrum of diseases, including invasive pneumococcal disease and pneumonia. Two types of pneumococcal vaccines are indicated for use in adults: 23-valent pneumococcal polysaccharide vaccines (PPV23) and a 13 ...
M. Tin Tin Htar   +10 more
semanticscholar   +1 more source

The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: an observational study

open access: yesBMC Research Notes, 2018
Objectives High-dose penicillin therapy is effective in approximately 90% of pneumococcal pneumonia cases diagnosed based on urinary pneumococcal antigen tests or Gram staining at admission.
Junpei Komagamine
doaj   +1 more source

Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)

open access: yesPneumonia
Background Streptococcus pneumoniae is an important cause of pneumonia in older adults, however, serotyping and indirect impact information from low and middle-income countries is lacking. Mongolia has a childhood 13-valent pneumococcal conjugate vaccine
Tuya Mungun   +21 more
doaj   +1 more source

Changes in the incidence, viral coinfection pattern and outcomes of pneumococcal hospitalizations during and after the COVID-19 pandemic

open access: yesPneumonia
Background The incidence of pneumococcal pneumonia in the context of the Coronavirus Disease 2019 (COVID-19) pandemic, along with the real-world data on the ratio of non-invasive to invasive pneumococcal pneumonia, is an area that has not been thoroughly
King-Pui Florence Chan   +6 more
doaj   +1 more source

The New Era of Pneumococcal Vaccination in Adults: What Is Next?

open access: yesVaccines
Streptococcus pneumoniae remains the leading cause of community-acquired pneumonia in adults and bacterial meningitis in children worldwide. In addition to pneumonia, invasive pneumococcal diseases (IPDs), such as bacteremia and meningitis, pose a ...
L. Ozisik
semanticscholar   +1 more source

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects

open access: yesGlobal Journal of Medicine and Public Health
Pneumococcus is an important cause of community acquired pneumonia and the commonest cause of community acquired bacterial pneumonia. It also causes invasive pneumococcal disease that increases hospitalization rates, economic burden, morbidity and ...
Salil Bendre   +2 more
doaj   +2 more sources

A Case of Pneumococcal Necrotizing Pneumonia in an Adult

open access: yesRespirology Case Reports
A 50‐year‐old woman with pneumococcal pneumonia developed cavitary lung lesions despite antibiotic therapy, leading to a diagnosis of necrotizing pneumonia.
Shimpei Kajie   +2 more
doaj   +1 more source

PNEUMOCOCCAL INFECTIONS AND VACCINATION — CAN PREVENTION REDUCE THE BURDEN OF THE ILLNESS

open access: yesПедиатрическая фармакология, 2007
The article gives the findings of the widest ranging research carried on in the USA to appraise the efficiency of vaccination by the study of the hospitalization frequency for pneumonia of any etiology and for dehydration after the program of ...
L.S. Namazova   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy